Stephen Simpson, CFA
Sep. 15, 2014, 2:20 AM
- Danaher (NYSE:DHR) has agreed to buy Nobel Biocare (OTCPK:NBHGY) in an all-cash deal valued at approximately $2.2B, including debt.
- Danaher says the acquisition would widen its market presence and make it the largest consumable and equipment player in the dental industry with sales approaching $3B.
- The deal is expected to be completed in late 2014 or early 2015, after which Nobel Biocare will continue to operate as a standalone company.
Apr. 15, 2013, 3:57 AM
Citi upgrades Dentsply (XRAY) to Buy from Neutral: "We believe that Dentsply is an attractive investment opportunity at its current price. We see upside to consensus through the restructuring of the implant manufacturing and potential for further acquisitions as the balance sheet improves." Citi advocates buying Straumann (SAUHF.PK, SAUHY.PK) and selling Noble (NBHGY.PK, NBHGF.PK), saying XRAY and Straumann are position to adopt a dual-brand model, Noble less so.| Apr. 15, 2013, 3:57 AM